Join the 'Diabetes, Type 1' group to help and get support from people like you. How it works

Diabetes, Type 1 Blog

Related terms: Insulin Dependent Diabetes, Juvenile onset diabetes, Type 1 Diabetes

U.S. Sees Drop in Deaths Linked to Diabetes

Posted 5 days ago by Drugs.com

TUESDAY, May 22 – Healthier lifestyles and better disease management led to a sharp drop in death rates for Americans with diabetes between 1997 and 2006, especially deaths caused by heart disease and stroke, a new federal government report shows. During that time, deaths from all causes for Americans with diabetes fell by 23 percent and deaths caused by heart disease and stroke in this group declined by 40 percent, according to the analysis of 1997-2004 National Health Interview Survey data on nearly 250,000 adults. One expert said the findings were reason for hope. "The encouraging news that less diabetic patients are dying from heart disease and stroke is a testament to multiple factors that have changed the playing field," said Dr. Tara Narula, a cardiologist at Lenox Hill Hospital in New York City. The study was conducted by researchers at the U.S. Centers for Disease Control and ... Read more

Related support groups: Diabetes, Type 2, Heart Disease, Ischemic Stroke, Diabetes, Type 1, Diabetes Mellitus

FDA Approves Levemir for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes

Posted 5 days ago by Drugs.com

PRINCETON, N.J., May 22, 2012 /PRNewswire/ – Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir® (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes. With the expansion of its pediatric indication, Levemir is now available for type 1 diabetes patients from age two through adulthood and adult patients with type 2 diabetes. The FDA approval now makes Levemir the first and only basal insulin analog for use in this young patient group. "Our biggest challenges and top priorities when treating some of the youngest children with type 1 diabetes are safety and reducing the risk of hypoglycemia," said Dr. Mark Sperling, MD, Editor-in-Chief of Pediatric Diabetes. "Levemir, with its approval from the FDA, is a particularly welcome addition to our treatment ... Read more

Related support groups: Diabetes, Type 1, Levemir, Insulin Detemir, Type 1 Diabetes

Diabetes Can Take a Toll on Your Emotions

Posted 10 days ago by Drugs.com

THURSDAY, May 17 – Many people know diabetes – both type 1 and type 2 – can take a serious toll on physical health. But these blood-sugar disorders also can affect your emotions and, in turn, your emotions can wreak havoc on your diabetes control. Extremes in blood-sugar levels can cause significant mood changes, and new research suggests that frequent changes in blood-sugar levels (called glycemic variability) also can affect mood and quality of life for those with diabetes. Depression has long been linked to diabetes, especially type 2. It's still not clear, however, whether depression somehow triggers diabetes or if having diabetes leads to being depressed. More recent research in people with type 1 diabetes has found that long periods of high blood-sugar levels can trigger the production of a hormone linked to the development of depression. People with type 1 diabetes no longer ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1

Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says

Posted 16 days ago by Drugs.com

FRIDAY, May 11 – Treatment with hyperbaric oxygen therapy helped prevent or slow the progression of type 1 diabetes in mice, according to new research. It is too early to say if the results might apply to humans, however. In mice, the treatment caused changes in the immune system's response to newly developing diabetes, and reduced the risk of diabetes between 20 and 40 percent. In the mice that still developed diabetes, the hyperbaric therapy delayed disease progression, the investigators found. "Hyperbaric oxygen therapy is a relatively non-harmful way of enhancing oxygen delivery to the tissues," said the study's senior author, Dr. Antonello Pileggi, director of the preclinical cell processing and translational models program at the Diabetes Research Institute of the University of Miami Miller School of Medicine. "We were able to suppress the transfer of the disease (in mice) before ... Read more

Related support groups: Diabetes, Type 1

Climate Change Could Be Tough on Seniors' Health: Study

Posted 9 Apr 2012 by Drugs.com

MONDAY, April 9 – Even small swings in temperatures could put elderly people with chronic illnesses such as diabetes, heart failure and lung disease at greater risk of death throughout the coming summer, a new study indicates. Researchers from the Harvard School of Public Health in Boston found temperature fluctuations related to climate change could claim thousands of lives every year. Experts predict climate change could increase variations in summer temperatures, particularly in the mid-Atlantic states and in parts of France, Spain and Italy. In these more volatile regions, this could pose a serious public health risk, the study authors claimed. "The effect of temperature patterns on long-term mortality has not been clear to this point. We found that, independent of heat waves, high day-to-day variability in summer temperatures shortens life expectancy," study author Antonella ... Read more

Related support groups: Diabetes, Type 2, Asthma, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Heart Failure, Diabetes, Type 1, Diabetes Mellitus, Respiratory Tract Disease

FDA Approves Levemir Pregnancy Category Change for Women with Diabetes

Posted 2 Apr 2012 by Drugs.com

Princeton, N.J. (April 02, 2012) /PRNewswire/ — Novo Nordisk, a world leader in diabetes care, announced today that the U.S. Food and Drug Administration (FDA) has approved Levemir (insulin detemir [rDNA origin] injection) for a pregnancy Category B classification, indicating that Levemir, when used in pregnant women with diabetes, did not increase the risk of harm to the unborn baby. The label update makes Levemir the first and only basal insulin analog to have this classification. Until this decision, NPH (human insulin) was considered the standard of care for diabetes in pregnancy. Now, Novo Nordisk is the only company that offers a complete portfolio of insulin analogs with a pregnancy Category B classification. The FDA category change was based on a review of a large, randomized controlled trial examining Levemir in pregnant women with type 1 diabetes. The study compared the safety ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Levemir, Diabetes Mellitus, Insulin Detemir

Treating Gum Disease May Help Diabetics Avoid Complications

Posted 23 Mar 2012 by Drugs.com

FRIDAY, March 23 – Treating gum disease in people with diabetes reduces their medical costs and hospitalizations, new research shows. The three-year study included diabetes patients with gum (periodontal) disease who were randomly selected either to receive periodontal therapy or no treatment (control group). Those in the treatment group underwent periodontal therapy in the first year and their gum health was maintained for the following two years. The patients in the control group had incomplete periodontal therapy before the study and did not receive regular periodontal maintenance during the study. The total annual per-patient cost of hospital admissions, doctor visits and overall medical care was an average of more than $1,800 lower in the treatment group than in the control group. The patients in the treatment group had 33 percent fewer hospital admissions. The study was to be ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus, Periodontitis

Type 1 Diabetes May Develop More Slowly Than Thought

Posted 21 Feb 2012 by Drugs.com

TUESDAY, Feb. 21 – Insulin production may continue for decades after the onset of type 1 diabetes, according to a new study. The findings add to growing evidence that the period of time for treatment after the onset of the disease is longer than previously believed, the Massachusetts General Hospital researchers said. "Traditionally, it was thought that beta cell function completely ceased in patients with advanced type 1 diabetes. However, data from this study and others suggest that the pancreas continues to function at some level even decades after the onset of type 1 diabetes," study leader Dr. Denise Faustman, director of the MGH Immunobiology Laboratory, said in a hospital news release. Beta cells are a type of cell in the pancreas that produce and store insulin. The researchers analyzed blood samples from 182 patients with type 1 diabetes and found that C-peptide production can ... Read more

Related support groups: Diabetes, Type 1

Pancreas May 'Taste' Fructose, Hinting at Links to Diabetes

Posted 6 Feb 2012 by Drugs.com

MONDAY, Feb. 6 – New research shows that the pancreas has sweet-taste receptors – like those found on the tongue – that can "taste" fructose. Fructose is a common ingredient in many foods and beverages. Nutrition experts have warned that Americans take in far too much fructose and the new findings might bolster their concerns. In lab studies of pancreas cells from both humans and mice, the researchers found that when the pancreas tastes fructose from foods, it responds by producing more insulin. Insulin is a hormone that allows sugar from the blood to enter the body's cells. However, excess levels of insulin, or an inefficient use of insulin, have been linked to obesity and type 2 diabetes, the researchers said. "The coolest thing in my mind is that we now understand that taste isn't only for the tongue. We have a whole slew of cells for controlling how we deal with sugars," said the ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Diabetes Takes Toll on Women's Hearing: Study

Posted 3 Feb 2012 by Drugs.com

FRIDAY, Feb. 3 – Diabetes is associated with hearing loss in women, especially if the blood sugar disease isn't well-controlled, new research indicates. The study, done by researchers at Henry Ford Hospital in Detroit, examined the medical records of 990 men and women who had hearing tests between 2000 and 2008. Patients with diabetes were divided into two groups: well-controlled and poorly controlled. Among women aged 60 to 75, hearing loss was 14 percent worse even in well-controlled diabetics compared to those without diabetes. That is not a clinically significant loss, noted study author Dr. Kathleen Yaremchuk, chairwoman of the department of otolaryngology at the Henry Ford Healthcare System in Detroit. "An individual might not notice it," Yaremchuk said. On the other hand, poorly controlled diabetics' hearing was 28 percent worse than the non-diabetic group's hearing. Younger ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Type 1 Diabetes Treatment Disappoints in Trial

Posted 1 Feb 2012 by Drugs.com

WEDNESDAY, Feb. 1 – The latest trial of a drug called GAD-alum to treat type 1 diabetes failed to show any significant improvement in the common markers of the blood sugar disease. The researchers, however, said they felt there were possible reasons for the failure of the current trial, and that specific groups of people still might benefit from GAD-alum. "Even if this study failed to reach its primary outcome, there were quite impressive results in certain subgroups, which supports the concept of using auto-antigens in the therapy of recent-onset type 1 diabetes," said study author Dr. Johnny Ludvigsson, a professor in the division of pediatrics, in the department of clinical and experimental medicine at Linkoping University in Sweden. Results of the study are published in the Feb. 2 issue of the New England Journal of Medicine. Funding for the study was provided by Diamyd Medical ... Read more

Related support groups: Diabetes, Type 1

Lifestyle Counseling Helps Diabetes Patients Control Blood Sugar

Posted 25 Jan 2012 by Drugs.com

WEDNESDAY, Jan. 25 – Incorporating lifestyle counseling into routine care for diabetes patients significantly reduces the time it takes them to reach their treatment goals, according to a new study. It included more than 30,000 diabetes patients with elevated blood glucose, blood pressure or cholesterol who received diet, exercise and weight loss counseling in a primary care setting for at least two years, with an average follow-up of nearly seven years. Using counseling in primary care reduced the time it took for the patients to lower their blood glucose, blood pressure and cholesterol levels, according to the researchers at Brigham and Women's Hospital in Boston. The more frequently patients received counseling, the quicker they reached their treatment goals. Those who received face-to-face counseling at least once a month took an average of 3.9 weeks to reach their goals, compared ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Rate of Leg, Foot Amputations Among Diabetics Drops: CDC

Posted 24 Jan 2012 by Drugs.com

TUESDAY, Jan. 24 – The rate of leg and foot amputations among diabetes patients aged 40 and older fell by 65 percent between 1996 and 2008, a new U.S. government study shows. The analysis of data from the National Hospital Discharge Survey found that the rate of non-traumatic lower-limb amputations among adults with diagnosed diabetes was 3.9 per 1,000 in 2008, compared with 11.2 per 1,000 in 1996, according to the U.S. Centers for Disease Control and Prevention. Non-traumatic lower-limb amputations are the result of circulatory problems that are common among people with diabetes, as opposed to traumatic amputations caused by injuries. In 2008, the rate of diabetes-related leg and foot amputations was higher for men than women (6 versus 1.9 per 1,000) and higher for blacks than for whites (4.9 versus 2.9 per 1,000). Adults aged 75 and older had the highest rate (6.2 per 1,000) of all ... Read more

Related support groups: Diabetes, Type 2, Diabetes, Type 1, Diabetes Mellitus

Health Tip: Store Insulin Properly

Posted 20 Jan 2012 by Drugs.com

-- Insulin is a lifesaver for many people with diabetes, but it must be stored correctly. The American Diabetes Association offers these guidelines for proper storage of insulin: Insulin typically is stored in the refrigerator, but it may be more painful when injected this way. Insulin stored at room temperature will last about a month. Don't keep your insulin in extremely hot or extremely cold temperatures. Never keep insulin in the car, in direct sunlight or in the freezer. Check the bottle's expiration date, and discard any insulin that's expired. Inspect the bottle before inserting the syringe to make sure the insulin looks as it should. Don't use insulin that has formed any crystals or clumps. Read more

Related support groups: Insulin, Lantus, Diabetes, Type 1, Humalog, Novolog, Lantus Solostar, Levemir, Novolin R, Lantus Solostar Pen, Novolin N, Humulin R, Humulin N, NovoLog FlexPen, Humalog KwikPen, Insulin Regular

More Known About Proteins That Cause Autoimmune Diseases

Posted 17 Jan 2012 by Drugs.com

TUESDAY, Jan. 17 – A new study says more than 32 million people in the United States have autoantibodies, which are proteins produced in the immune system that attack the body's tissues. Autoantibodies can cause autoimmune diseases such as rheumatoid arthritis, lupus and type 1 diabetes, researchers say. Researchers examined blood serum samples taken from almost 4,800 people who participated in the 1994-2004 U.S. National Health and Nutrition Examination Survey. The research team was looking for the most common type of autoantibody, called antinuclear antibodies (ANA). The overall prevalence of antinuclear antibodies was about 14 percent and was slightly higher in blacks than in whites. Frequency generally increased with age and was higher in women than in men, with the female-to-male ratio peaking at 40 to 49 years and then declining with age. "The peak of autoimmunity in females ... Read more

Related support groups: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Diabetes, Type 1, Autoimmune Disorders, Lupus Erythematosus

Ask a Question

Further Information

Related Condition Support Groups

Hypoglycemia, Diabetic Ketoacidosis (in DM Type I), Diabetic Coma (in DM Type I), Diabetes Mellitus

Related Drug Support Groups

Victoza, Lantus, Humalog, Novolog, Lantus Solostar, Levemir, Novolin R, Humulin R, Novolin N, view more... Humulin N, Symlin, NovoLog FlexPen, octreotide, Humalog KwikPen, liraglutide, gotu kola, insulin regular, NovoLog Mix 70/30, Novolin 70/30, Sandostatin, Apidra, Humulin N Pen, Symlin Pen, Humalog Pen, lavender, Novolin R Innolet, Novolin R PenFill, Lantus OptiClik Cartridge, Iletin NPH, Novolin N Innolet, Humalog Mix 50/50 Pen, Humalog Mix 75/25, Novolin N PenFill, Apidra Solostar, insulin lispro, Insulin Pork Mix, ReliOn/Novolin 70/30, insulin lispro/insulin lispro protamine, Exubera, SymlinPen 60, ReliOn/Novolin R, Novolin 70/30 PenFill, Novolin 70/30 Innolet, Humulin 70/30 Pen, Humalog Mix 50/50, ReliOn/Novolin N, SymlinPen 120, NovoLog PenFill, Novolog Mix 70/30 PenFill, Humalog Mix 50/50 KwikPen, Humalog Mix 75/25 KwikPen, NovoLog Mix 70/30 FlexPen, Humalog Mix 75/25 Pen, Iletin II NPH Pork, insulin zinc extended, insulin zinc, pramlintide, Lente Iletin II, Sandostatin LAR Depot, insulin isophane/insulin regular, insulin isophane, insulin detemir, insulin aspart/insulin aspart protamine, insulin glargine, insulin glulisine, insulin inhalation, rapid acting, Humulin U, Iletin II Regular Pork, Insulin Lente Pork, Novolin L, Iletin Lente, Iletin II Lente Pork, Humulin 70/30, Humulin L, insulin aspart, Velosulin BR, Iletin Regular, Humulin R (Concentrated), Insulin Purified NPH Pork, Humulin 50/50